Koh, S., Tham, K., Razvi, K., Oei, P., Lim, F., Roy, A., . . . GYNAECOLOGY, O. &. (2016). Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?

Koh, S.C.L., K.-F Tham, K. Razvi, P.-L Oei, F.-K Lim, A.-C Roy, R.N.V Prasad, and OBSTETRICS & GYNAECOLOGY. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.

Koh, S.C.L., et al. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.